Myopenic Obesity Determined by Fat Mass Percentage Predicts Risk of Aspirin-Induced Bleeding in Chinese Older Adults

References

• Antithrombotic Trialists’ (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet. 2009;373:1849–1860. doi:10.1016/S0140-6736(09)60503-1
   PubMed Web of Science ®Google Scholar
• Casado-Arroyo R, Bayrak F, Sarkozy A, et al. Role of ASA in the primary and secondary prevention of cardiovascular events. Best Pract Res Clin Gastroenterol. 2012;26:113–123.
   PubMed Web of Science ®Google Scholar
• Capodanno D, Angiolillo DJ. Aspirin for primary cardiovascular risk prevention and beyond in diabetes mellitus. Circulation. 2016;134:1579–1594.
   PubMed Web of Science ®Google Scholar
• Andreotti F, Rocca B, Husted S, et al.; Group ESCTW. Antithrombotic therapy in elderly individuals: expert position paper of the European Society of cardiology working group on thrombosis. Eur Heart J. 36;2015:3238–3249. doi:10.1093/eurheartj/ehv304
   PubMed Web of Science ®Google Scholar
• Li L, Geraghty OC, Mehta Z, et al. Age-specific risks, severity, time course, and outcome of bleeding on longterm antiplatelet treatment after vascular events: a population-based cohort study. Lancet. 2017;390:490–499. doi:10.1016/S0140-6736(17)30770-5
   PubMed Web of Science ®Google Scholar
• Rao G, Powell-Wiley TM, Ancheta I, et al. American heart association obesity committee of the council on lifestyle and cardiometabolic health. Identification of obesity and cardiovascular risk in ethnically and racially diverse populations: a scientific statement from the American Heart Association. Circulation. 2015;132:457–472. doi:10.1161/CIR.0000000000000223
   PubMed Web of Science ®Google Scholar
• NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–2642. doi:10.1016/S0140-6736(17)32129-3
   PubMed Web of Science ®Google Scholar
• Afshin A, Forouzanfar MH, Reitsma MB, et al.; GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27. doi:10.1056/NEJMoa1614362
   PubMed Web of Science ®Google Scholar
• Furtado RHM, Giugliano RP, Dalcoquio TF, et al. Increased bodyweight and inadequate response to aspirin in individuals with coronary artery disease. J Thromb Thrombolysis. 2019;48(2):217–224. doi:10.1007/s11239-019-01830-z
   PubMed Web of Science ®Google Scholar
• Mourikis P, Zako S, Dannenberg L, et al. Aspirin antiplatelet effects are associated with body weight. Vascul Pharmacol. 2020;125–126:106635. doi:10.1016/j.vph.2019.106635
   PubMed Web of Science ®Google Scholar
• Rothwell PM, Cook NR, Michael Gaziano J, et al. Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomized trials. Lancet. 2018;392:387–399. doi:10.1016/S0140-6736(18)31133-4
   PubMed Web of Science ®Google Scholar
• Wang X, Zhu Q, Wu Y, et al. Effect of body weight on bleeding events of aspirin in ischemic stroke or transient ischemic attack patients. J Clin Pharm Ther. 2022;47:1684–1689. PMID: 35748660. doi:10.1111/jcpt.13722
   PubMed Web of Science ®Google Scholar
• Zamboni M, Mazzali G, Fantin F, et al. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388–395. doi:10.1016/j.numecd.2007.10.002
   PubMed Web of Science ®Google Scholar
• Feng H, Wang X, Zhao T, et al. Myopenic obesity determined by visceral fat area strongly predicts long-term mortality in cirrhosis. Clin Nutr. 2021;40(4):1983–1989. doi:10.1016/j.clnu.2020.09.016
   PubMed Web of Science ®Google Scholar
• Powell BD, Lennon RJ, Lerman A, et al. Association of body mass index with outcome after percutaneous coronary intervention. Am J Cardiol. 2003;91:472–476. doi:10.1016/S0002-9149(02)03252-6
   PubMed Web of Science ®Google Scholar
• Delhaye C, Wakabayashi K, Maluenda G, et al. Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference? Am Heart J. 2010;159:1139–1146. doi:10.1016/j.ahj.2010.03.011
   PubMed Web of Science ®Google Scholar
• Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation. 2011;123:2736–2747. doi:10.1161/CIRCULATIONAHA.110.009449
   PubMed Web of Science ®Google Scholar
• Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. PMID: 32033882. doi:10.1016/j.jamda.2019.12.012
   PubMed Web of Science ®Google Scholar
• Yuji M. Examination committee of criteria for obesity disease in Japan; Japan Society for the study of obesity. New criteria for “obesity disease”. Jpn Circ J. 2002;66(11):987–992.
   Google Scholar
• Batsis JA, Mackenzie TA, Bartels SJ, et al. Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999–2004. Int J Obes. 2016;40(5):761–767. doi:10.1038/ijo.2015.243
   PubMed Web of Science ®Google Scholar
• Kamo N, Kaido T, Hamaguchi Y, et al. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation. Clin Nutr. 2019;38:2202–2209. doi:10.1016/j.clnu.2018.09.019
   PubMed Web of Science ®Google Scholar
• Alpert MA, Omran J, Bostick BP. Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function. Curr Obes Rep. 2016;5:424–434. doi:10.1007/s13679-016-0235-6
   PubMed Web of Science ®Google Scholar
• Patrono C, Rocca B. Type 2 diabetes, obesity, and aspirin responsiveness. J Am Coll Cardiol. 2017;69(6):613–615. doi:10.1016/j.jacc.2016.11.049
   PubMed Web of Science ®Google Scholar
• Rocca B, Fox KAA, Ajjan RA, et al. Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis. Eur Heart J. 2018;39(19):1672–1686f. doi:10.1093/eurheartj/ehy066
   PubMed Web of Science ®Google Scholar
• Petrucci G, Zaccardi F, Giaretta A, et al. Obesity is associated with impaired responsiveness to once‐daily low‐dose aspirin and in vivo platelet activation. J Thromb Hemost. 2019;17:885–895. doi:10.1111/jth.14445
   Web of Science ®Google Scholar
• Maree AO, Curtin RJ, Dooley M, et al. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease. J Am Coll Cardiol. 2005;46:1258–1263. doi:10.1016/j.jacc.2005.06.058
   PubMed Web of Science ®Google Scholar
• Rocca B, Santilli F, Pitocco D, et al. The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes. J Thromb Hemost. 2012;10:1220–1230. doi:10.1111/j.1538-7836.2012.04723.x
   Web of Science ®Google Scholar
• Davi G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA. 2002;288:2008–2014. doi:10.1001/jama.288.16.2008
   PubMed Web of Science ®Google Scholar
• Sankaralingam S, Kim RB, Padwal RS. The impact of obesity on the pharmacology of medications used for cardiovascular risk factor control. Can J Cardiol. 2015;31:167–176. doi:10.1016/j.cjca.2014.10.025
   PubMed Web of Science ®Google Scholar
• Xiting W, Meilin L. Correlation between body composition and aspirin-induced bleeding in older patients with coronary heart disease. J Clinical Cardiol. 2021;37(1):32–37. doi:10.13201/j.issn.1001-1439.2021.01.007
   Google Scholar
• Wang X, Wang H, Zheng Q, et al. Outcomes Associated with 50 mg/d and 100 mg/d aspirin for the prevention and management of cardiovascular disease in Chinese elderly: single-center interim analysis of a multicenter, prospective, observational study. Int J Gen Med. 2022;15:7089–7100. doi:10.2147/IJGM.S384375
   PubMed Web of Science ®Google Scholar
• Editorial Board of Chinese Journal of Cardiovascular Disease (Online edition). Expert consensus on prevention and treatment of digestive tract injury associated with oral antithrombotic drugs. Chin J Cardiovasc Dis. 2021;4:e1000081.
   Google Scholar
• Donini LM, Busetto L, Bischoff SC, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15(3):321–335. doi:10.1159/000521241
   PubMed Web of Science ®Google Scholar